Cyclohexenone Compounds for Atopic Dermatitis Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Atopic dermatitis (AD) is characterized by skin inflammation and immune system dysregulation, with current treatments only reducing severity and frequency of flares without a known cure, and existing therapies fail to address the underlying immune response effectively.
Innovation Solution
Administration of a therapeutically effective amount of a cyclohexenone compound with a specific structure, which can be derived from natural products or synthesized, to reduce skin inflammation, restore skin barrier function, and modulate cytokine production, thereby alleviating symptoms of AD.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments (steroid creams, moisturizing creams) are used to manage atopic dermatitis symptoms, then skin inflammation and itching can be temporarily relieved, but the underlying immune system dysfunction and skin barrier defects remain untreated, leading to recurring flares
Solution Approach 1:
The patent extracts and addresses the root cause of atopic dermatitis by targeting the underlying immune system dysfunction and skin barrier defects rather than just treating symptoms. The composition is designed to specifically correct immune dysregulation and repair skin barrier function, separating the treatment of root causes from symptom management.
Solution Approach 2:
The composition takes preliminary action by preventing immune system dysregulation and skin barrier breakdown before they lead to inflammation and flares. By strengthening the skin barrier and modulating the immune response in advance, the treatment prevents the cascade that leads to symptomatic episodes.
2Object-affected harmful factors
If steroid creams are applied to reduce inflammation during flares, then acute symptoms are suppressed, but the treatment does not address the persistent immune dysfunction and may cause side effects with prolonged use
Solution Approach 1:
The patent converts the harmful immune overresponse that causes inflammation into a beneficial regulated immune function. The composition modulates the immune system to transform the pathological immune activation into a balanced, protective immune response that maintains skin health without causing inflammation.
Solution Approach 2:
The composition acts as an intermediary between the immune system and the skin barrier, mediating their interaction to prevent pathological inflammation. It provides a bridging effect that coordinates immune responses with skin barrier integrity, ensuring that immune activity protects rather than damages the skin.
3Adaptability or versatility
If multiple treatments are used to address different aspects of atopic dermatitis, then comprehensive symptom management is achieved, but treatment complexity and the number of products required increases
Solution Approach 1:
The patent merges multiple therapeutic functions into a single composition that simultaneously addresses immune system dysfunction, skin barrier defects, and inflammation. The composition integrates immunomodulation, barrier repair, and anti-inflammatory activities in one unified treatment product.
Solution Approach 2:
The composition is designed with universal applicability to treat all aspects of atopic dermatitis pathophysiology. It performs multiple functions including immune modulation, skin barrier reinforcement, and anti-inflammatory action, making it a versatile single-agent treatment that replaces multiple specialized therapies.
Data Source
Figure 1
Figure 2A~2E
Figure 3A~3C
AI summary
The present invention provides methods and compositions for treating atopic dermatitis by cyclohexenone compounds.